Cargando...
Antihypertensive Efficacy of Olmesartan Medoxomil, a New Angiotensin II Receptor Antagonist, as Assessed by Ambulatory Blood Pressure Measurements
Olmesartan medoxomil is a new angiotensin II receptor blocker. In this randomized, double‐blind, placebo‐controlled study, the efficacy and safety of olmesartan medoxomil was assessed in 334 patients with moderate to severe essential hypertension. Patients were randomized to receive placebo; 5, 20,...
Gardado en:
| Publicado en: | J Clin Hypertens (Greenwich) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Le Jacq Communications, Inc.
2007
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8101835/ https://ncbi.nlm.nih.gov/pubmed/12368570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2002.01051.x |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|